Loading stock data…
$49.89-0.43 (-0.84%)
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide.
Heartflow, Inc. in the Healthcare sector is trading at $49.89 with a market capitalization of $4.3B. Wall Street consensus targets $46.00 (9 analysts), implying a -7.8% move over the next 12 months. The stock is currently near its 52-week high of $54.32, remaining 52.7% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $64.08M↑ | $52.59M↑ | $49.13M↑ | $46.28M↑ | $43.42M |
| Gross Profit | $53.19M↑ | $42.16M↑ | $39.06M↑ | $35.41M↑ | $32.78M |
| Operating Income | -$17.90M↑ | -$22.02M↓ | -$17.75M↓ | -$15.10M↓ | -$13.71M |
| Net Income | -$15.74M↑ | -$27.38M↓ | -$24.39M↑ | -$50.85M↓ | -$9.20M |
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personal...